Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: LoLoLoLita who wrote (3729)	5/1/1998 6:54:00 AM
From: Linda Kaplan	Read Replies (1) \| Respond to of 7041

DAvid, Just take the time to read the recent posts. The CEO was recently quoted as giving figures to the press that were at variance to the results of the trials. I realized then that the hype for Zonagen was coming from the CXO of Zonagen. I didn't know it myself till I saw that he was promoting the company to the press with figures that are not valid. It doesn't matter what other companies do in terms of pre-screening. What matters is what's told the public in regard to that. If the CEO says that X% the population will be helped, then those figures should reflect the pre-screening, or he's not telling the truth. For example, if 20% of the population is eliminated and the population is also confined to those with MILD problems and 30% of those remaining are helped, would you say that 40% of the entire population is helped by this drug? In my opinion, if you said it, and you were the CEO you would be giving information you know to be inaccurate.. If you're a scientist, act like one, and do some DD before you take such an attitude. Linda